CFH rs4810424: What Your Genotype Means

What each genotype means

Variant Classification and Chromosome Location

The single nucleotide polymorphism rs4810424 represents a single base-pair change situated within the complement factor H (CFH) gene cluster on chromosome 1q31.3. This genomic region contains multiple tightly packed genes that encode critical proteins involved in immune system moderation, notably CFH and several CFH-related (CFHR) genes. Genetic variants in non-coding and intronic regions around CFH frequently travel together across generations in specific ancestral blocks known as haplotypes. Because rs4810424 resides within this dense linkage network, researchers often investigate whether it acts as a functional regulatory element or merely serves as a genetic marker tagging neighboring functional changes. Public genomic repositories, such as dbSNP and Ensembl, classify rs4810424 as a common biallelic polymorphism. While high-impact coding variants like Y402H (rs1061170) have well-characterized direct biochemical consequences, intronic and regulatory variants like rs4810424 are typically evaluated for subtle influences on gene expression, splicing mechanics, or regional chromatin organization.

Biological Function of the CFH Gene

The CFH gene provides the genetic blueprint for complement factor H, an essential plasma glycoprotein that functions as a primary negative regulator of the alternative complement pathway. As part of the innate immune system, the complement cascade plays an indispensable role in recognizing microbial invaders, clearing cellular debris, and orchestrating inflammatory responses. However, unchecked activation can rapidly injure healthy self-tissues. Complement factor H circulates throughout the vascular system and binds to target structures such as cell-surface glycosaminoglycans and activated complement fragment C3b. By acting as a molecular brake, factor H accelerates the decay of active convertase enzymes and facilitates the proteolytic cleavage of C3b, preventing runaway tissue destruction. In ocular structures, particularly the retina and underlying choroid, factor H plays a vital role in preventing localized, chronic complement-driven inflammation that would otherwise damage photoreceptors and adjacent retinal pigment epithelium cells.

Research Associations and Evidence Strength

Genome-wide association studies and candidate locus evaluations have repeatedly implicated the CFH genomic region in susceptibility to age-related macular degeneration (AMD), as well as rare atypical hemolytic uremic syndromes and renal glomerulopathies. While strong, robust statistical evidence centers on the well-known missense variant rs1061170, the evidence directly linking rs4810424 itself to disease susceptibility remains limited. Observational studies assessing rs4810424 suggest modest statistical correlations with altered AMD predisposition, but these effects are often attenuated or largely accounted for once analyses adjust for linkage disequilibrium with primary driver variants in the locus. Because rs4810424 exhibits strong co-inheritance patterns with other regional markers, disentangling its independent contribution requires fine-mapping and biochemical validation. Consequently, modern ocular genetics views rs4810424 as having limited isolated clinical significance compared to major established complement risk loci, representing an incremental component of overall polygenic background rather than an independent causative mutation.

Population Frequency and Diversity

The alleles of rs4810424 occur at varying frequencies across global populations, reflecting distinct evolutionary histories and genetic drift. In individuals of European ancestry, the minor allele maintains a relatively high frequency, generally ranging between 0.35 and 0.45 according to large reference sequencing datasets like gnomAD and early candidate association cohorts. Conversely, population genetics databases indicate that allele distributions can diverge noticeably in non-European groups, including East Asian, South Asian, and African populations. In several non-European ancestries, the local haplotype architecture of chromosome 1q31 differs substantially, altering the degree of linkage between rs4810424 and nearby causal alleles. Because most early complement association studies focused predominantly on cohorts of European descent, risk associations observed at this locus may not directly translate across diverse ethnic backgrounds, underscoring the necessity for multi-ancestry genomic research when evaluating polygenic eye health markers.

Interpreting Your Results and Actionable Guidance

Learning your rs4810424 genotype can offer educational perspective on your unique genetic profile, but it does not represent an eye disease diagnosis or a guarantee of future health outcomes. Major medical organizations, including the American Academy of Ophthalmology, do not recommend routine direct-to-consumer genetic testing for macular degeneration risk stratification outside of specialized clinical trials, because no approved preventive gene therapies currently target individual CFH polymorphisms. Age-related macular degeneration is an inherently multifactorial condition driven by a convergence of genetic architecture, advancing age, and substantial environmental influences. Key modifiable factors—such as tobacco avoidance, eating an antioxidant-rich diet containing dark leafy greens and omega-3 fatty acids, managing blood pressure, and shielding eyes from intense ultraviolet light—exert profound influences on retinal longevity. If you have concerns about your vision or a family history of retinal disease, schedule comprehensive dilated examinations with an optometrist or ophthalmologist.

Frequently asked questions

Sources & further reading

Related variants in CFH